# Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

> **NCT03537456** · NA · COMPLETED · sponsor: **Mesoestetic Pharma Group S.L.** · enrollment: 39 (actual)

## Conditions studied

- Facial Rejuvenation

## Interventions

- **DEVICE:** mRDX-02-17

## Key facts

- **NCT ID:** NCT03537456
- **Lead sponsor:** Mesoestetic Pharma Group S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-29
- **Primary completion:** 2019-02-14
- **Final completion:** 2019-02-24
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2019-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537456, "Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03537456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*